Galderma Group Ag

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

September 16, 2026

Galderma opens new U.S. and Latin America headquarters in Miami

August 24, 2026

Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

August 11, 2026

Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year

July 23, 2026

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

July 20, 2026

GALD:SIX

CH · CHF

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

GDERF:OTC

US · USD

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

GALDY:OTC

US · USD

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

PY3:GETTEX

DE · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

1GALD:MIL

IT · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

A407X6:LSX

DE · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

PY3:FWB

DE · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

GALD:BX

CH · CHF

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

GALD:VIE

AT · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

A407X6:LS

DE · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

GALDZ:AQUISUK

GB · CHF

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.

PY3:TRADEGATE

DE · EUR

Alternate listing for Galderma Group Ag; the primary context on this page is PY3:DUS.